This inventor holds 2 USPTO granted patents. Top assignee: New England Biolabs, Inc.. Active years: 1994-2005.
Location History:
- Portsmouth, NH (US) (1994)
- Beverly, MA (US) (2005)
Company Filing History:
Years Active: 1994-2005
Title: The Innovations of Toby E Claus
Introduction
Toby E Claus is an accomplished inventor based in Beverly, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of restriction endonucleases. With a total of 2 patents, his work has advanced the understanding and application of genetic engineering techniques.
Latest Patents
One of his latest patents is titled "Method for cloning and producing the Msel restriction endonuclease." This invention provides a method for cloning a restriction-modification system, allowing for the production of the target modification methylase. This method ensures full protection during all growth phases when the cognate restriction enzyme is present, facilitating the cloning of the MseI restriction-modification system. Another notable patent is "Isolated DNA encoding the NotI restriction endonuclease and related." This invention outlines a method for cloning and producing the NotI restriction endonuclease by introducing the restriction endonuclease gene from Nocardia otitidis-caviarum into a host. The process includes fermenting the host and purifying the NotI restriction endonuclease from the fermented host.
Career Highlights
Toby E Claus is currently employed at New England Biolabs, Inc., where he continues to innovate in the field of molecular biology. His work at this esteemed company has allowed him to collaborate with other leading scientists and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Richard D Morgan and Elisabeth A Raleigh. Their collaborative efforts have further enhanced the research and development of new biotechnological methods.
Conclusion
Toby E Claus is a prominent figure in the field of biotechnology, with a focus on restriction endonucleases. His patents and work at New England Biolabs, Inc. reflect his dedication to advancing genetic engineering techniques. His contributions continue to impact the scientific community positively.